Exposure to fumes containing high concentrations of PAHs
RMA definition
Being exposed to fumes containing high concentrations of polycyclic aromatic hydrocarbons means:
(i) working with creosote;
(ii) working with coal-tar pitch, coal-tar or asphalt;
(iii) working in the coal gasification, coke production, carbon electrode manufacture or the coal-tar distillation industry;
(iv) being exposed to coke oven emissions; or
(v) inhaling diesel engine exhaust or combustion products in an enclosed space – this 'inhalation' exposure applies to reasonable hypothesis cases only.
Information about the scope and nature of service duties may be found in Physical requirements, duties, and workplace hazards of specific military occupations which also contains an embedded table: Military occupations with fumes and irritants component.
Malignant neoplasm of the bladder - Exposure to fumes containing high concentrations of PAHs Factor
Last eviewed for CCPS 12 March 2008.
INVESTIGATIVE DOCUMENTS
| Type | Title | PDF Format | Word Format |
|---|---|---|---|
| Claimant Report | Polycyclic Aromatic Hydrocarbons - Malignant Neoplasm of the Bla |
PRELIMINARY QUESTIONS [39113]
39123 there is some evidence that exposure to fumes containing high concentrations of polycyclic aromatic hydrocarbons may be a factor in the development of the condition under consideration.
39182 the veteran has been exposed to fumes containing high concentrations of polycyclic aromatic hydrocarbons at some time.
39179 the veteran has established the causal connection between the exposure to fumes containing high concentrations of polycyclic aromatic hydrocarbons and VEA service for the clinical onset of malignant neoplasm of the bladder.
39180 the veteran has established the causal connection between the exposure to fumes containing high concentrations of polycyclic aromatic hydrocarbons and operational service for the clinical onset of malignant neoplasm of the bladder.
or
39181 the veteran has established the causal connection between the exposure to fumes containing high concentrations of polycyclic aromatic hydrocarbons and eligible service for the clinical onset of malignant neoplasm of the bladder.
CLINICAL ONSET AND OPERATIONAL SERVICE [39180]
39183 the veteran has been exposed to fumes containing high concentrations of polycyclic aromatic hydrocarbons as specified in the reasonable hypothesis Statement of Principles for malignant neoplasm of the bladder for a cumulative period of at least 5000 hours at some time.
39185 the veteran was exposed to fumes containing high concentrations of polycyclic aromatic hydrocarbons as specified in the reasonable hypothesis Statement of Principles for malignant neoplasm of the bladder for a cumulative period of at least 5000 hours before the clinical onset of the condition under consideration.
39187 operational service made a material contribution to the veteran's exposure to fumes containing high concentrations of polycyclic aromatic hydrocarbons as specified in the reasonable hypothesis Statement of Principles for malignant neoplasm of the bladder for a cumulative period of at least 5000 hours before the clinical onset of the condition under consideration.
CLINICAL ONSET AND ELIGIBLE SERVICE [39181]
39184 the veteran has been exposed to fumes containing high concentrations of polycyclic aromatic hydrocarbons as specified in the balance of probabilities Statement of Principles for malignant neoplasm of the bladder for a cumulative period of at least 10000 hours at some time.
39186 the veteran was exposed to fumes containing high concentrations of polycyclic aromatic hydrocarbons as specified in the balance of probabilities Statement of Principles for malignant neoplasm of the bladder for a cumulative period of at least 10000 hours before the clinical onset of the condition under consideration.
39188 eligible service made a material contribution to the veteran's exposure to fumes containing high concentrations of polycyclic aromatic hydrocarbons as specified in the balance of probabilities Statement of Principles for malignant neoplasm of the bladder for a cumulative period of at least 10000 hours before the clinical onset of the condition under consideration.